Imre, Gergely; Kraehling, Verena; Eichler, Madeleine et al.
The sphingosine kinase 1 activator, K6PC-5, attenuates Ebola virus infectionISCIENCE. Bd. 24. H. 4. 2021
Sadanandam, Anguraj; Bopp, Tobias; Dixit, Santosh et al.
A blood transcriptome-based analysis of disease progression, immune regulation, and symptoms in coronavirus-infected patientsCELL DEATH DISCOVERY. Bd. 6. H. 1. 2020
Yurugi, Hajime; Zhuang, Yinyin; Siddiqui, Farid et al.
A subset of flavaglines inhibits KRAS nanoclustering and activationJOURNAL OF CELL SCIENCE. Bd. 133. H. 12. 2020
Lauer, Alina; Wolf, Philipp; Mehler, Dorothea et al.
Biofabrication of SDF-1 Functionalized 3D-Printed Cell-Free Scaffolds for Bone Tissue RegenerationINTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. Bd. 21. H. 6. 2020
Roth, Klaus Edgar; Betz, Simon; Schmidtmann, Irene et al.
Biological responses to individualized small titanium implants for the treatment of focal full-thickness knee cartilage defects in a sheep modelKNEE. Bd. 27. H. 3. 2020 S. 1078-1092
Wiechmann, Svenja; Maisonneuve, Pierre; Grebbin, Britta M. et al.
Conformation-specific inhibitors of activated Ras GTPases reveal limited Ras dependency of patient-derived cancer organoidsJOURNAL OF BIOLOGICAL CHEMISTRY. Bd. 295. H. 14. 2020 S. 4526-4540
Klein, Anja; Baranowski, Andreas; Ritz, Ulrike et al.
Effect of bone sialoprotein coating on progression of bone formation in a femoral defect model in ratsEUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY. Bd. 46. H. 2. 2020 S. 277-286
Bogucka, Katarzyna; Pompaiah, Malvika; Marini, Federico et al.
ERK3/MAPK6 controls IL-8 production and chemotaxisELIFE. Bd. 9. 2020
Bogucka, Katarzyna; Marini, Federico; Rosigkeit, Sebastian et al.
ERK3/MAPK6 is required for KRAS-mediated NSCLC tumorigenesisCANCER GENE THERAPY. 2020
Bogucka, Katarzyna; Marini, Federico; Rosigkeit, Sebastian et al.
ERK3/MAPK6 is required for KRAS-mediated NSCLC tumorigenesis (October, 10.1038/s41417-020-00245-w, 2020)CANCER GENE THERAPY. 2020